Vertex Pharmaceuticals
RANK
23
Courtesy of Vertex Pharmaceuticals
Company Information
As of 5/23/2022
Country
U.S.
Headquarters
Boston
Industry
Pharmaceuticals
CEO
Reshma Kewalramani
Website
Company Type
Public
Ticker
VRTX
Revenues ($M)
$7,574.4
Profits ($M)
$2,342.1
Market Value ($M)
$66,436.9
Employees
3,900
Market value as of March 31, 2022.
Fastest-Growing CompaniesAs of 10/28/21
Revenue 3 Yr Growth Rank
19
Revenue 3 Yr Annual Growth Rate
39%
EPS 3 Yr Growth Rank
15
EPS 3 Yr Annual Growth Rate
100%
Total Return 3 Yr Rank
83
Total Return 3 Yr Annual Rate (Through June 30, 2021)
6%
Beat S&P 500 3 Yr Return (18.6%)
no
Current Streak
2
Years on List
2
Sector
Health Care
